| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.084 | 0.003 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.21 | 0.004 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |